Amrit spent his first eight years in the industry working with hundreds of R&D leaders at universities, biotechs, and large pharma companies to develop commercial products from discovery to market approval. ​

• Founded Advanced Peptides in 2007, a biopharma CRO
• Holds patents in chemistry for global commercialized products​
• One of INC Magazine’s top 20 innovators in healthcare

Seth spent his first six years in the industry working in corporate business development and as a startup entrepreneur in high throughput biology, followed by 12 years as a growth strategy consultant for Fortune 500 biopharma.

• In 1999 founded Molecularware, winning the MIT 50K competition, and successfully exited in 2003
• As Principal at TSG partners and Managing General Partner at Vectur LLC, Seth focused on corporate growth and buy-side M&A, as well as VC backed startup sell-side M&A

Amelia has more than 20 years of experience creating and growing businesses. She has launched and grown five companies from start-up to success by creating winning strategies and high-performance teams that drive growth. Amelia has a unique understanding of how to structure people, culture, and process to fuel high-growth companies.

• Culture and people management expert for early-stage and post Series B companies; has held multiple C-level titles
• Previously Associate Partner and Pharma industry consultant for Monitor Group (now Monitor Deloitte)

Brian is a biopharmaceutical manufacturing expert with more than 20 years of experience in the industry. He comes to SmartLabs from a mid-sized molecular engineering company, where he ran their healthcare business. Prior to that, he was the GM for GE Healthcare’s Biomanufacturing Solutions business.

• Developed turnkey manufacturing solutions for mAb production with a single use platform
• Worked with Congress to bring generic manufacturing back to the US
• Launched and ran cGMP sites, most recently a facility in Spain

Saquib came to SmartLabs from Boston Scientific, where he was the Head of Global Design and Construction. Saquib has more than 20 years of experience building R&D Laboratory and GMP manufacturing facilities, including the new 500K SQFT Boston Scientific facility in Malaysia. 

• Prior responsibilities of managing 9M SQFT across 150 sites in 12 countries
• Led design and construction of over 2M SQFT
• Experience rooted in commercial clean rooms, FDA validated GMP, R&D facilities, and utility infrastructures

Hans has decades of experience in life science and technology companies while holding a variety of technical and management positions. Throughout his career, he has focused on commercializing advanced technology projects in partnership with corporations and VCs.

• Built and led the global diagnostics platform RAPIDPoint at Novartis and Bayer
• Winner of 2 R&D 100 awards in life sciences
• Multiple positions as CEO and COO

Jillian came to SmartLabs from New York City government, where she held several leadership and strategic advisor positions. She has nearly a decade of experience in real estate transactions and development, public-private partnerships, and large-scale capital strategy and planning.

• Created a strategic plan to complete $13B of comprehensive renovations for public housing leveraging multiple sources of capital and partnerships
• Led the development of a new state-of-the-art tech hub in Union Square
• Developed and executed policies to fight the COVID-19 pandemic in New York City, execute large-scale capital projects, and streamline internal operations

Robin came to SmartLabs with over 25 years of experience in auditing and developing finance functions at companies of all sizes and across a variety of industries; she has spent the last thirteen years focused on Biotechnology and Healthcare. Robin began her professional at Big Four firms PwC and Deloitte, then moved into global companies Bank of America and Fidelity Investments to continue her focus on internal controls and internal financial operations. She eventually transitioned to smaller companies where she applied her expertise in internal controls to strengthen their finance functions, develop financial operations in early stages of corporate growth, as well as create initial budgets and cash forecasting models that ensure both scalability and the ability to forecast and predict growth patterns that align with overall corporate strategies.

• Has been involved in a variety of M&A transactions, raising more than $350 million in debt and equity deals, and working closely with multiple Private Equity and Investment Banking firms
• The first CFO at StrataDx, where the company grew to $30 million in revenue during her tenure
• Led a new department at Bank of America, overseeing the reconciliation and financial controls of the Bank's internal deposit and general ledger accounts

Cole has been working with SmartLabs since its inception and has been an integral part of its growth over the years. A civil engineer and attorney who is passionate about real estate, construction, and development. Cole has worked with developers, as well as real estate and property management companies of all sizes throughout the country.

• Was a partner at the dynamic business transaction and litigation firm Strang Scott where he served as counsel for businesses of all sizes on matters ranging from business formation and complex commercial transactions to all forms of dispute resolution.
• Founded Woodward Cass, a business law firm representing biotech and pharma companies with clients ranging from initial start-ups to large, national companies

Working as a trusted partner to CEOs, Ben has raised over $1 billion of equity, debt, and project capital for 12 companies and completed 11 Merger and Acquisition transactions during his career.

• Former head of finance for Cambridge Innovation Center
• Previous Management Consultant at McKinsey
• Brought investment banking and asset management divisions of Credit Suisse to Middle East

A seasoned Sales and Marketing professional, Graham is also an experienced molecular biologist and former cancer research scientist. Blending his expertise in the lab with his methodical sales and business development talents, Graham has helped grow companies like DiscoverX (acquired by Eurofins), Artel, and PerkinElmer.

• Successful sales penetration into 85% of the top 30 worldwide biopharma
• Full R&D value chain sales development: discovery to clinical stage